Clinical trial
Safety of a Real-time Continuous Glucose Monitor-based Insulin Bolus Calculator: The "CGM-IBC" Study
NCT05229445 is registered in ClinicalTrials.gov with Welldoc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of a Real-time Continuous Glucose Monitor-based Insulin Bolus Calculator: The "CGM-IBC" Study
- Lead sponsor
- Welldoc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 5, 2022
- Completion date
- September 28, 2022
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.